SC
VCEL icon

Scholtz & Company’s Vericel Corp VCEL Stock Holding History

Scholtz & Company’s Portfolio VCEL Stock Details VCEL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-50,573
Closed -$2.15M – 54
2025
Q2 		$2.15M Buy
50,573
+454
+0.9% +$18.9K 0.94% 35
2025
Q1 		$2.24M Buy
50,119
+2,459
+5% +$132K 1.11% 30
2024
Q4 		$2.62M Buy
47,660
+4,562
+11% +$231K 1.25% 25
2024
Q3 		$1.82M Buy
43,098
+13,525
+46% +$644K 0.86% 32
2024
Q2 		$1.36M Buy
+29,573
New +$1.39M 0.58% 32

Other funds holding VCEL

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
CCA
Conestoga Capital Advisors Wayne, Pennsylvania $4.6B AUM 16.08% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return
GCM
Geneva Capital Management Milwaukee, Wisconsin $4.71B AUM 6.32% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return
GKIM
GW&K Investment Management Boston, Massachusetts $11.3B AUM 31.98% 1-Year Est. Return

Scholtz & Company's VCEL Position: Q3 2025 in Review

Scholtz & Company sold out of Vericel Corp (VCEL) in Q3 2025, closing a stake of 50,573 shares — an estimated $2.15M sold.

Scholtz & Company first reported a position in VCEL in Q2 2024 and held it in 5 quarters. The position peaked at $2.62M in Q4 2024. 249 funds tracked by Wall St. Rank hold VCEL as of Q3 2025.

  • Scholtz & Company reported no remaining Vericel Corp position as of Q3 2025 after selling out during the quarter.
  • Scholtz & Company sold 50,573 Vericel Corp shares in Q3 2025, an estimated $2.15M.
  • Scholtz & Company first reported a position in Vericel Corp in Q2 2024 and held it in 5 quarters.
  • Scholtz & Company's Vericel Corp position peaked at $2.62M in Q4 2024.
  • 249 funds tracked by Wall St. Rank held Vericel Corp as of Q3 2025.

Based on Scholtz & Company's 13F filing for Q3 2025, filed 12 Nov 2025.